Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A rechallenge protocol for successfully reinstituting Fabrazyme therapy in patients with previous IgE antibody production or positive skin testing

A rechallenge protocol for successfully reinstituting Fabrazyme therapy in patients with previous IgE antibody production or positive skin testing. American Society of Human Genetics. 2005.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.